Michael Kavanagh
Vermogen: 3 M $ op 31-07-2026
Vermogen: 3 M $ op 31-07-2026
Michael Kavanagh is President, CEO & Executive Director at Nanosonics Ltd. since 2013.
Mr. Kavanagh was Senior Vice President-Global Marketing at Cochlear Ltd. from 2003 to 2013.
Mr. Kavanagh earned an MBA from The University of Queensland and completed undergraduate studies at University College Dublin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NANOSONICS LIMITED 0,48% | 11-12-2025 | 1.432.788 ( 0,48% ) | 3 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NANOSONICS LIMITED | Algemeen Directeur | 21-10-2013 |
| Bedrijven | Functie | Einde |
|---|---|---|
| COCHLEAR LIMITED | Verkoop & Marketing | 01-10-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Nanosonics Ltd.
Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
Cochlear Ltd.
Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau